Showing results (1-10 of 113) with videos related to
Sort By:
Pageof 12
Current Oncology Reports|July 31, 2012
Active immunotherapy: current state of the art in vaccine approaches for NHLM Lia PalombaBlood|November 16, 2013
In the spotlight: a novel CD37 antibody-drug conjugateM Lia Palomba, Anas YounesHematology/Oncology Clinics of North America|September 8, 2018
First-Generation and Second-Generation Bruton Tyrosine Kinase Inhibitors in Waldenström MacroglobulinemiaKimon V Argyropoulos, M Lia PalombaFrontiers in Oncology|July 16, 2024
Chimeric antigen receptor T-cell therapy for aggressive B-cell lymphomasBei Hu, Victoria Korsos, M Lia PalombaHematology. American Society of Hematology. Education Program|December 7, 2024
T-cell-based therapies for treating relapsed or refractory mantle cell lymphomaZachary D Epstein-Peterson, M Lia PalombaAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
Chimeric Antigen Receptor T-Cell Therapies for Aggressive B-Cell Lymphomas: Current and Future State of the ArtJeremy S Abramson, Matthew Lunning, M Lia PalombaTherapeutic Advances in Hematology|August 6, 2016
Ibrutinib in Waldenström macroglobulinemia: latest evidence and clinical experienceJorge J Castillo, M Lia Palomba, Ranjana Advani, et al.General Hospital Psychiatry|July 1, 2008
Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussionTomer T Levin, Alberto Cortes-Ladino, Mark Weiss, et al.Blood Reviews|August 21, 2022
Targeting CD19 for diffuse large B cell lymphoma in the era of CARs: Other modes of transportationDavid Sermer, Pavania Elavalakanar, Jeremy S Abramson, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 13, 2018
Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen EscapeCarl DeSelm, M Lia Palomba, Joachim Yahalom, et al.Pageof 12